VividWhite is an Australian, clinical stage, medical device company that is designing, engineering and manufacturing novel technology and products to treat ophthalmic conditions. VividWhite’s lead technology in human clinical trials is a microfluidic surgical implant that carries fluid from the front of the eye, to disperse in the surrounding tissue to relieve intra-ocular pressure and treat glaucoma.

Glaucoma is the leading cause of irreversible blindness worldwide, and the second most common cause in Australia. More than 300,000 Australians have glaucoma and the World Health Organisation (WHO) estimates that there are currently 80 million people globally living with glaucoma.

VividWhite

Org chart

Teams

Offices